Situation: Mature, global animal health care company wanted to expand into human health care. The company was unsure whether their lead product was ready to advance to IND-enabling activities. The company also lacked expertise in human clinical product development.
Value: The client developed infrastructure and skilled staff internally to work on future pharmaceutical programs. The rapid advancement of the lead program into the clinic was critical in securing additional funds to support this business expansion.